Circulating biomarkers of cognitive decline and dementia

scientific article

Circulating biomarkers of cognitive decline and dementia is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.CCA.2005.06.015
P698PubMed publication ID16139826
P5875ResearchGate publication ID7621136

P50authorFrancesco PanzaQ37830901
Cristiano CapursoQ46872206
P2093author name stringVincenzo Solfrizzi
Orlando Todarello
Alessia D'Introno
Antonio Capurso
Anna Maria Colacicco
Sabrina A Capurso
Vincenza Pellicani
Giuseppe Pietrarossa
Vito Santamato
P433issue1-2
P921main subjectdementiaQ83030
biomarkerQ864574
P304page(s)91-112
P577publication date2005-09-01
P1433published inClinica Chimica ActaQ5133740
P1476titleCirculating biomarkers of cognitive decline and dementia
P478volume364

Reverse relations

cites work (P2860)
Q36963331APOE ε4 and the associations of seafood and long-chain omega-3 fatty acids with cognitive decline
Q37387826Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting
Q41039610Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.
Q38119019Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease
Q35700985Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles
Q34373769Cholesterol and copper affect learning and memory in the rabbit.
Q33916282Cognitive impairment in chronic obstructive pulmonary disease
Q34056793Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.
Q79346218Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly
Q36457368Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype
Q35878063Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cells
Q36246699Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults
Q42087791Elucidating the link between the modifiable risk factors of Alzheimer's disease and neuroinflammation
Q38845041Glial biomarkers in human central nervous system disease
Q37010478Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy
Q35024426Interactions between the apolipoprotein E ε4 allele status and adverse childhood experiences on depressive symptoms in older adults
Q37448495KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients
Q37064329KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients
Q44884500Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia
Q50867647Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease.
Q36366891Neurochemical biomarkers in Alzheimer's disease and related disorders.
Q26995483Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors
Q47754524Neutrophil and platelet to lymphocyte ratios in people with subjective, mild cognitive impairment and early Alzheimer's disease.
Q38955402Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.
Q92182516Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review
Q42139898Phellodendron amurense and Its Major Alkaloid Compound, Berberine Ameliorates Scopolamine-Induced Neuronal Impairment and Memory Dysfunction in Rats
Q36919567Plasma Amyloid-β Peptides and Homocysteine in Depression in the Homebound Elderly
Q55396744Probiotics improve insulin resistance status in an experimental model of Alzheimer's disease.
Q60934511Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study
Q33647579Serum lipids are related to Alzheimer's pathology in nursing home residents
Q36052866Some hormone, cytokine and chemokine levels that change across lifespan vary by cognitive status in male Fischer 344 rats
Q50771095Stability of amyloid-β peptides in plasma and serum.
Q36902286Systemic and acquired immune responses in Alzheimer's disease
Q90552914The Involvement of NLRP3 on the Effects of Minocycline in an AD-Like Pathology Induced by β-Amyloid Oligomers Administered to Mice
Q38016800The development of effective biomarkers for Alzheimer's disease: a review
Q30830414The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies
Q37710280The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly.
Q37418999The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).
Q43059453Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease
Q53297551[New perspectives in the laboratory diagnosis of dementia].

Search more.